X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
hiv (12) 12
humans (12) 12
children (11) 11
female (10) 10
infectious diseases (9) 9
male (9) 9
infant (8) 8
africa (7) 7
drug therapy (7) 7
hiv infection (7) 7
immunology (7) 7
mortality (7) 7
child (6) 6
child, preschool (6) 6
hiv infections - drug therapy (6) 6
human immunodeficiency virus--hiv (6) 6
lopinavir (6) 6
aids/hiv (5) 5
early antiretroviral treatment (5) 5
highly active antiretroviral therapy (5) 5
life sciences (5) 5
pediatrics (5) 5
research (5) 5
tuberculosis (5) 5
west africa (5) 5
adolescent (4) 4
adolescents (4) 4
age (4) 4
anti-hiv agents - administration & dosage (4) 4
antiretroviral therapy (4) 4
antiviral agents (4) 4
burkina faso (4) 4
caregivers (4) 4
cohort (4) 4
cote-divoire (4) 4
hiv patients (4) 4
infants (4) 4
nevirapine (4) 4
prevalence (4) 4
south-africa (4) 4
africa south of the sahara - epidemiology (3) 3
analysis (3) 3
anti-hiv agents - therapeutic use (3) 3
antiretroviral drugs (3) 3
care and treatment (3) 3
diagnosis (3) 3
drug therapy, combination (3) 3
efavirenz (3) 3
health aspects (3) 3
hiv infections - epidemiology (3) 3
human health and pathology (3) 3
infant, newborn (3) 3
pharmacokinetics (3) 3
research article (3) 3
therapy (3) 3
treatment outcomes (3) 3
[ sdv ] life sciences [q-bio] (2) 2
[sdv]life sciences [q-bio] (2) 2
acceptability (2) 2
adherence (2) 2
adult (2) 2
antiretroviral treatment (2) 2
burkina faso - epidemiology (2) 2
care (2) 2
complications and side effects (2) 2
cote d'ivoire (2) 2
cross-sectional studies (2) 2
dideoxynucleosides - administration & dosage (2) 2
disclosure (2) 2
dosage and administration (2) 2
drug combinations (2) 2
early infant diagnosis (2) 2
failure (2) 2
growth (2) 2
hiv infection in children (2) 2
hiv infections - diagnosis (2) 2
hiv infections - immunology (2) 2
hiv infections - therapy (2) 2
hiv infections - virology (2) 2
hiv-infected children (2) 2
lopinavir - administration & dosage (2) 2
medicine (2) 2
microbiology (2) 2
mothers (2) 2
opportunities (2) 2
outcomes (2) 2
pharmacology & pharmacy (2) 2
practice guidelines as topic (2) 2
protease inhibitor (2) 2
protease inhibitors (2) 2
randomised clinical trial (2) 2
risk factors (2) 2
ritonavir - administration & dosage (2) 2
treatment outcome (2) 2
treatment simplification (2) 2
vih (2) 2
virological outcomes (2) 2
virus diseases (2) 2
young adult (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Clinical Pharmacology, ISSN 0306-5251, 12/2017, Volume 83, Issue 12, pp. 2729 - 2740
Aims A clinical study was conduct in HIV‐infected children to evaluate the prophylactic doses of cotrimoxazole [sulfamethoxazole (SMX) and trimethoprim (TMP)]... 
pharmacokinetics | HIV | children | trimethoprim | sulfamethoxazole | GENETIC POLYMORPHISMS | PNEUMOCYSTIS-CARINII-PNEUMONIA | COTE-DIVOIRE | PREVENTION | HUMAN-IMMUNODEFICIENCY-VIRUS | TRIAL | METABOLISM | ZAMBIAN CHILDREN | PHARMACOLOGY & PHARMACY | TRIMETHOPRIM-SULFAMETHOXAZOLE | Anti-Bacterial Agents - blood | Coinfection | Humans | Child, Preschool | Pneumonia, Pneumocystis - prevention & control | Infant | Male | Metabolic Clearance Rate | HIV Infections - immunology | Computer Simulation | Female | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacokinetics | World Health Organization | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Administration, Oral | AIDS-Related Opportunistic Infections - immunology | Cote d'Ivoire | Pneumonia, Pneumocystis - immunology | HIV Protease Inhibitors - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - blood | AIDS-Related Opportunistic Infections - microbiology | AIDS-Related Opportunistic Infections - prevention & control | Burkina Faso | Models, Biological | Anti-Bacterial Agents - pharmacokinetics | HIV Infections - drug therapy | Lopinavir - therapeutic use | Nonlinear Dynamics | Pneumonia, Pneumocystis - microbiology | Anti-Bacterial Agents - administration & dosage | Practice Guidelines as Topic | Highly active antiretroviral therapy | Antiviral agents | Analysis | HIV patients | Children | Drug therapy | HIV (Viruses) | Antibacterial agents | HIV infection | Pharmacokinetics
Journal Article
by Dahourou, Désiré Lucien and Amorissani-Folquet, Madeleine and Malateste, Karen and Amani-Bosse, Clarisse and Coulibaly, Malik and Seguin-Devaux, Carole and Toni, Thomas and Ouédraogo, Rasmata and Blanche, Stéphane and Yonaba, Caroline and Eboua, François and Lepage, Philippe and Avit, Divine and Ouédraogo, Sylvie and Van de Perre, Philippe and N'Gbeche, Sylvie and Kalmogho, Angèle and Salamon, Roger and Meda, Nicolas and Timité-Konan, Marguerite and Leroy, Valériane and Désiré Lucien Dahourou, Lucien Dahourou and Colette Ouédraogo, Ouedraogo and Sawadogo, Mamadou and Wilfried Somé, Some and Désiré Sondo, Sondo and Thio, Elisabeth and Barry, Mamadou and Hiembo, William and Fla Kouéta, Koueta and Ouattara, Adama and Moussa Ouédraogo, Ouedraogo and Rasmata Ouédraogo, Ouedraogo and Sylvie Ouédraogo, Ouedraogo and Congo, Bernadette and Barry, Rose and Yé, Diarra and Congo, Malika and Edouard Minéné, Minene and Coulibaly, Marie and Angèle Kalmogho, Pierre Innocent Guissou and Kam, Ludovic and Emile Ouédraogo, Ouedraogo and Lassana Sangaré, Sangare and Tiendrebeogo, Sylvestre and Ky-Zerbo, Odette and Anglaret, Xavier and Clarisse Amani-Bossé, Amani-Bosse and Danel, Christine and Serge Eholié, Eholie and Didier Ekouévi, Ekouevi and Kanga, Eulalie and Kouadio, Suzanne and Lennaud, Séverin and Aimé Oga, Maxime and N'Dri-Yoman, Thérèse and Dainguy, Evelyne and Kouassi, Beugre and Kouassi, Jean-Claude and Gladys Oka, Oka and Keita, Kader and Lambin, Jean Yves and Tanoh, François Eboua and Aka, Addi Edmond and Aka-Dago, Hortense and Sylvie N'Gbeche, N'Gbeche and Messou, Eugène and Emieme, Arlette and Fatoumata Koné, Kone and Hervé Menan, Menan and Vincent Yapo, Yapo and Abo, Kouamé and Ahoba, Irma and Aka, David and Kodo, Carine and Siaka, Touré and Touré, Pety and Ekouevi, Fassinou and Viho, Ida and Tanoh, Anthony Richard and Olivier Blé, Ble and Koné, Berté and Dattez, Sophie and Desmonde, Sophie and Jesson, Julie and Karcher, Sophie and Jérôme Le Carrou, Le Carrou and Valériane Leroy, Leroy and Ndondoki, Camille and Touret, Pierre and Bouyssou, Caroline and Geneviève Chêne, Chene and Valérie Conte, Conte and Gabillard, Delphine and Valérie Journot, Journot and Devaux, Carole and Schmit, Jean-Claude and Stéphane Blanche, Blanche and Hirt, Deborah and Rouzioux, Christine and ... and MONOD Study Grp and MONOD Study Group
BMC Medicine, ISSN 1741-7015, 04/2017, Volume 15, Issue 1, p. 85
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 01/2016, Volume 19, Issue 1, pp. 20601 - n/a
Journal Article
The Pan African medical journal, ISSN 1937-8688, 2018, Volume 30, p. 293
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis... 
treatment | Burkina Faso | Tuberculosis | failure | Mortality | Medical diagnosis | Multivariate analysis | Patients | Clinical outcomes | Variables | Human immunodeficiency virus--HIV | Data collection | Population | Drug therapy | Failure | Public health
Journal Article
OPEN FORUM INFECTIOUS DISEASES, ISSN 2328-8957, 07/2019, Volume 6, Issue 7, p. ofz276
Background. The NEVEREST-3 (South Africa) and MONOD-ANRS-12206 (Cote d'Ivoire, Burkina Faso) randomized trials found that switching to efavirenz (EFV) in human... 
cost-effectiveness | SOUTH-AFRICA | INFECTIOUS DISEASES | treatment strategies | Africa | MICROBIOLOGY | DOLUTEGRAVIR | IMMUNOLOGY | NEVIRAPINE | PROTEASE INHIBITOR | RITONAVIR-BOOSTED LOPINAVIR | HIV | PHARMACOKINETICS | VIROLOGICAL FAILURE | pediatrics | PEDIATRIC-PATIENTS | 1ST-LINE | HIV-INFECTED CHILDREN
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2017, Volume 61, Issue 7
The MONOD ANRS 12206 trial was designated to assess simplification of a successful lopinavir (LPV)-based antiretroviral treatment in HIV-infected children... 
Pharmacokinetics | Efavirenz | Children | VARIABILITY | HIV | children | PLASMA-LEVELS | POPULATION PHARMACOKINETICS | pharmacokinetics | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | efavirenz | Index Medicus
Journal Article
Journal Article
Journal Article